- Previous Close
1,970.40 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 2,300.00 - Volume
0 - Avg. Volume
17,722 - Market Cap (intraday)
269.641B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
36.77 - EPS (TTM)
52.04 - Earnings Date --
- Forward Dividend & Yield 0.31 (0.02%)
- Ex-Dividend Date May 13, 2024
- 1y Target Est
--
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and indication exams, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation. In addition, it operates health centers, which includes metabolic surgery and nutrition, thyroid and parathyroid, physical medicine and rehabilitation, endometriosis, hemodynamics service, and dialysis centers. Further, the company offers research and training services, as well as newborn, school, and accident agreements. Instituto de Diagnóstico S.A. was founded in 1961 and is headquartered in Providencia, Chile.
www.indisa.cl3,065
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: INDISA.SN
View MorePerformance Overview: INDISA.SN
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INDISA.SN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INDISA.SN
View MoreValuation Measures
Market Cap
269.64B
Enterprise Value
362.72B
Trailing P/E
36.79
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.13
Price/Book (mrq)
2.47
Enterprise Value/Revenue
1.52
Enterprise Value/EBITDA
21.95
Financial Highlights
Profitability and Income Statement
Profit Margin
3.04%
Return on Assets (ttm)
3.18%
Return on Equity (ttm)
6.83%
Revenue (ttm)
239.07B
Net Income Avi to Common (ttm)
7.28B
Diluted EPS (ttm)
52.04
Balance Sheet and Cash Flow
Total Cash (mrq)
10.65B
Total Debt/Equity (mrq)
95.24%
Levered Free Cash Flow (ttm)
11.88B